Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

30-10-2017 | Image

Figure 1: Allopurinol hypersensitivity includes MPE, AHS and allopurinol-induced SCAR.

AHS and allopurinol-induced SCAR overlap considerably. Allopurinol-induced SCAR includes SJS/TEN and DRESS. The size of the circles in this figure in no way relate to the frequency of these adverse reactions. Abbreviations: AHS, allopurinol hypersensitivity syndrome; DRESS, drug reaction with eosinophilia and systemic symptoms; MPE, maculopapular eruption; SCAR, severe cutaneous adverse reactions; SJS, Stevens–Johnson syndrome; TEN, toxic epidermal necrolysis.

print
PRINT
Image Credits